Samira Chaibakhsh

Samira Chaibakhsh

Auto-generated profile, based on publicly available information

Samira Chaibakhsh

Eye Research Center, Eye Department, School of Medicine, The Five Senses Health Institute, Iran University of Medical Sciences, Tehran, Iran

Research Focus & Metrics

Academic Career Length

9Years (2018-Present)

(Calculated once Scilit publication data is synced: current year − year of first publication + 1)

Representative Publications

View All Publications
1 December 2019 in Psychiatry Research
Verified
Journal Article
Closed access
AMAtieh Modarresi
Atieh Modarresi
SCSamira Chaibakhsh
Samira Chaibakhsh
NKNeda Koulaeinejad
Neda Koulaeinejad
SKShahram Rafieian Koupaei
Shahram Rafieian Koupaei

21 November 2022 in Lasers in Medical Science
Verified
Journal Article
Closed access
PDF file
KMKatayoon Montazeri
Katayoon Montazeri
MFMohammad Farhadi
Mohammad Farhadi
Reza FekrazadReza Fekrazad
Reza Fekrazad
SCSamira Chaibakhsh
Samira Chaibakhsh
SMSaeid Mahmoudian
Saeid Mahmoudian

28 May 2022 in Asian Pacific Journal of Cancer Prevention
Verified
Journal Article
Open access
PDF file
MNMasood Naseripoor
Masood Naseripoor
FAFatemeh Azimi
Fatemeh Azimi
RMReza Mirshahi
Reza Mirshahi
GKGolnaz Khakpoor
Golnaz Khakpoor
APAsma Poorhosseingholi
Asma Poorhosseingholi
SCSamira Chaibakhsh
Samira Chaibakhsh
Background: Uveal melanoma (UM) is the most common primary intraocular malignancy in adults arising from uveal tissue melanocytes. Considering limited population based studies, we performed a meta-analysis of uveal melanoma incidence rate in worldwide. Methods: For this meta-analysis, the electronic database of PubMed, Scopus, Embase and Google Scholar were utilized. Qualified Cohort studies and registry system databases were included in the study. Trend analysis and the estimation of incidences were reported. Thereafter subgroup analysis on gender and diagnostic tests were performed. Analyses were done using random effect models. Results: A total of 22 publications were eligible to include in the meta-analysis. The incidence rates of uveal melanoma were 5.74 (95%CI: 4.37-7.11) and 7.30 (95%CI: 6.36-8.24) in North America and Europe respectively. The analysis showed a significant decreasing trend in North America. It was expected that the risk of UM decreased approximately 0.09 (SE=0.04) per million persons per year. No significant trend was detected in Europe. There was not any significant difference between the incidence rate in male and female (6.58, 95%CI: 5.42-7.75 vs. 5.44, 95%CI: 4.40-6.48). In addition, the reported incidence rates in different diagnostic approaches were similar (6.61, 95%CI: 5.63-7.58 in clinical vs. 6.67, 95%CI: 5.83-7.42 in histological). Conclusion: This analysis confirmed in recent decades, there has been a steady decline in the incidence in North America. However, in European countries where they still have the highest incidence worldwide, the trend was stable. It seems that international melanoma registration collaboration can conduct a unified, multicentral study to estimate the worldwide incidence of UM and impact of different factors on its rate.

3 March 2023 in Indian Journal Of Ophthalmology
Verified
Journal Article
Open access
FAFatemeh Abdi
Fatemeh Abdi
AAAli Aghajani
Ali Aghajani
SHSara Hemmati
Sara Hemmati
DMDelaram Moosavi
Delaram Moosavi
AGArzhang Gordiz
Arzhang Gordiz
SCSamira Chaibakhsh
Samira Chaibakhsh
Pediatric rhegmatogenous retinal detachment (RRD) is an issue of debate regarding its surgical outcomes and prognosis because of diagnosis delay, more complex etiological factors, and a higher prevalence of postoperative complications. This meta-analysis aims to evaluate the anatomical and visual outcomes of pediatric RRD and the factors that influence the treatment results. This is the first meta-analysis on this subject. We searched the relevant publications in the electronic databases of PubMed, Scopus, and Google Scholar. Eligible studies were included in the analysis. Anatomical success after one surgery and the final rates of success were estimated. Subgroup analysis was performed to find the rate of success in patients with different prognostic factors. This meta-analysis showed that the total rate of success after one surgery was about 64%, which implies that performing the first surgery was enough to get anatomical reattachment in most of the patients. The final anatomical rate of success was about 84%. In terms of visual acuity, the pooled results revealed statistically significant (P < 0.001) improvement in postoperative vision, with a 0.42 reduction in log of minimum angle of resolution (logMAR). The final rate of success was significantly lower in eyes with proliferative vitreoretinopathy (PVR) (about 25% lower in eyes with PVR, P < 0.001) and in the presence of congenital anomalies (about 36% lower in congenital cases, P = 0.008). Myopic RRD had a significantly better anatomical success rate. In conclusion, this study shows that there is a high chance of anatomical success after pediatric RRD treatment. The presence of PVR and congenital anomalies was associated with a poorer prognosis.

18 July 2022 in Pain Management
Verified
Journal Article
Closed access
ABArash Babaei-Ghazani
Arash Babaei-Ghazani
SMSara Moradnia
Sara Moradnia
MAMaziar Azar
Maziar Azar
BFBijan Forogh
Bijan Forogh
TATannaz Ahadi
Tannaz Ahadi
BEBina Eftekharsadat
Bina Eftekharsadat
Aim: The main assessment of this study is to analyze the efficiency of ultrasound-guided dextrose prolotherapy against corticosteroid injections for the treatment of carpal tunnel syndrome. Materia...
1

1 July 2020 in International Journal of Infectious Diseases
Verified
Journal Article
Open access
PDF file
SCSamira Chaibakhsh
Samira Chaibakhsh
APAsma Pourhoseingholi
Asma Pourhoseingholi
MVMohsen Vahedi
Mohsen Vahedi
Background: Severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2), a new coronavirus, was diagnosed in China in December 2019. Around the globe, a total of 71429 were infected up to February 17, 2020, with 98.9% of cases in China. On March 11, 2020, the World Health Organization (WHO) characterized the COVID-19 as ‘pandemic’. Rapid positive worldwide incidence was the motivation behind this study to investigate the incidence and mortality globally. Methods: We used the data published by the WHO until March 9, 2020. Non-parametric tests and change point analysis were used for inferences. Results: Change point analysis for Iran and China and the world excluding China for the first 20 days revealed around 78, 195 and 2 further new cases per day, respectively. Italy had a big jump in incidence on the 36th day. Similarly, a sharp rise of positive cases was reported for the world on the 35th day. China successfully controlled the ascending reports of incidence on the 23rd day. Mortality in China and the world were almost similar for the first 20 days. There was an ascending incidence trend with two change points in Italy (30th and 36th days) and one change point in Iran on the 17th day. Mortality in the world jumped remarkably after day 42 with an estimation of almost more than 25 deaths per day. Conclusion: The incidence of COVID-19 varied by regions; however, after March 11, it became ‘pandemic’. It was observed that after about 6 days with an emergence of sharp increase in incidences, there would be a mutation in mortality rate. On the other hand, the importance of ‘on-time’ quarantine programs in controlling this virus was confirmed.